Acadia Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Acadia Pharmaceuticals Inc in one report.
- Save hours of research time and resources with
our up-to-date Acadia Pharmaceuticals Inc Strategy Report
- Understand Acadia Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Acadia Pharmaceuticals Inc (Acadia) is a biopharmaceutical company that discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company's lead product Nuplazid, focused on R&D, and partnership with Neuren are its strengths whereas decrease in net working capital is an area of concern. The market potential of Parkinson’s disease, changing demographics, and strategic agreements could provide growth opportunities to the company. However, competition, stringent government regulations, and uncertain R&D outcomes could affect the future business prospects of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward